What is the current size of the global microarray market?

The microarray market size was valued at USD 5.46 billion in 2023 and expected to surpass USD 13.81 billion by 2034. Read More

What is the CAGR of microarray market from forecast period 2024 to 2034?

The microarray market is anticipated to grow at a compound annual growth rate of 8.8% from forecast period 2024 to 2034. Read More

What are the factors driving the microarrays market growth?

Factors such as growing incidence of cancer worldwide, increasing expenditure on research and development in the healthcare sector, growing number of applications of microarrays, advances in the fields of proteomics and genomics, developments in bioinformatics, evolution of software’s, growing awareness regarding personalized medicines, and increasing preference for DNA based microarrays are driving the growth of microarray market. Read More

How much was the market share of North American region in the microarrays market?

In 2023, the North American region dominated the worldwide market with a market share of higher than 38%. Read More

Which companies are functioning in the worldwide microarray market?

The key companies functioning in the worldwide microarray market are Illumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Merck & Co., Inc., PerkinElmer, Inc., Arrayit Corporation, Bio-Rad Laboratories, GE Healthcare, Molecular Devices, LLC, and Affymetrix among others. Read More

Which product segment was dominated the overall microarray market in 2023?

Among the product segment, consumables dominated the overall market in 2023. Recurrence and bulk procurement of consumables for numerous research applications is the foremost factor attributing to its large market share. Read More

Why Asia-Pacific region is anticipated to witness the rapid growth rate in the microarray market from forecast period 2024 to 2034?

The Asia-Pacific is anticipated to witness the rapid growth rate, on account of increasing investment by major manufacturers, high prevalence of cancer, and growing per-capita healthcare expenditure. Read More

Microarray Market Size, Share, and Trends 2024 to 2034

Microarray Market (By Product: Consumables, Software & Services, and Instruments; By Type: DNA Microarrays, Protein Microarrays, and Other Microarrays; By Application: Agriculture, Research Applications, Drug Discovery, Diseases Diagnostics, and Other Applications; By End User: Research & Academic Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Other End Users) - Global Industry analysis, Market Size, Share, Growth, Trends, Regional Outlook and Forecast 2024 - 2034

Last Updated : July 2024
Report Code : 1201
Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Microarray Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Microarray Market

5.1. Covid-19: Microarray Industry Impact
5.2. Microarray Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Microarray Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Microarray Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Microarray Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Growing incidence of cancer worldwide
6.1.1.2. Increasing expenditure on research and development in the healthcare sector
6.1.2. Market Restraints
6.1.2.1. Stringent Regulations
6.1.3. Market Opportunities
6.1.3.1. Growing awareness regarding personalized medicines
6.1.3.2. Increasing preference for DNA based microarrays

Chapter 7. Global Microarray Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Microarray Market Revenue by Market Players
7.1.1.2. MicroarrayMarket Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Microarray Market, By Product

8.1. Microarray Market, by Product, 2024-2034
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Software & Services
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Instruments
8.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Microarray Market, By Type

9.1. Microarray Market, by Type, 2024-2034
9.1.1. DNA Microarrays
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Protein Microarrays
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Other Microarrays
9.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Microarray Market, By Application

10.1. Microarray Market, by Application, 2024-2034
10.1.1. Agriculture
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Research Applications
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Drug Discovery
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Diseases Diagnostics
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Other Applications
10.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Microarray Market, By End User

11.1. Microarray Market, by End User, 2024-2034
11.1.1. Research & Academic Institutes
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Pharmaceutical & Biotechnology Companies
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Diagnostic Laboratories
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Other End Users
11.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Microarray Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Product(2021-2034)
12.1.2. Market Revenue Forecast by Type(2021-2034)
12.1.3. Market Revenue Forecast by Application (2021-2034)
12.1.4. Market Revenue Forecast by End User (2021-2034)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2021-2034)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2021-2034)
12.2. Europe
12.2.1. Market Revenue Forecast by Product (2021-2034)
12.2.2. Market Revenue Forecast by Type (2021-2034)
12.2.3. Market Revenue Forecast by Application (2021-2034)
12.2.4. Market Revenue Forecast by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2021-2034)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2021-2034)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product (2021-2034)
12.3.2. Market Revenue Forecast by Type (2021-2034)
12.3.3. Market Revenue Forecast by Application (2021-2034)
12.3.4. Market Revenue Forecast by End User (2021-2034)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2021-2034)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2021-2034)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product (2021-2034)
12.4.2. Market Revenue Forecast by Type (2021-2034)
12.4.3. Market Revenue Forecast by Application (2021-2034)
12.4.4. Market Revenue Forecast by End User (2021-2034)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2021-2034)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2021-2034)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product (2021-2034)
12.5.2. Market Revenue Forecast by Type (2021-2034)
12.5.3. Market Revenue Forecast by Application (2021-2034)
12.5.4. Market Revenue Forecast by End User (2021-2034)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2021-2034)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2021-2034)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2021-2034)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2021-2034)

Chapter 13. Company Profiles

13.1. Illumina, Inc.
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin
13.1.4. Recent Developments and Strategies
13.2. Agilent Technologies, Inc.
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin
13.2.4. Recent Developments and Strategies
13.3. Thermo Fisher Scientific, Inc.
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin
13.3.4. Recent Developments and Strategies
13.4. Merck & Co., Inc.
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin
13.4.4. Recent Developments and Strategies
13.5. PerkinElmer, Inc.
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin
13.5.4. Recent Developments and Strategies
13.6. Arrayit Corporation
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin
13.6.4. Recent Developments and Strategies
13.7. Bio-Rad Laboratories
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin
13.7.4. Recent Developments and Strategies
13.8. GE Healthcare
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin
13.8.4. Recent Developments and Strategies
13.9. Molecular Devices, LLC
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin
13.9.4. Recent Developments and Strategies
13.10. Affymetrix
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin
13.10.4. Recent Developments and Strategies

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

We use cookies to improve your experience

Microarray Market Size To Hit USD 13.81 Bn By 2034

List of Contents